RHBDF1 & RHBDF2 Knockout A549 Cell Line

The choice depends on whether you are studying combined iRhom-ADAM17 function in lung cancer biology or testing TACE-mediated EGFR ligand shedding's contribution to NSCLC progression. The Double Knockout line is uniquely valuable for asking whether ADAM17 function is required for lung cancer cell phenotypes — combined iRhom1 + iRhom2 loss creates a functional ADAM17 null in a lung cancer context. Single-iRhom rescue in the double knockout enables paralog-specific lung cancer studies. For lung cancer ADAM17 research, the EDITGENE RHBDF1 & RHBDF2 Double Knockout in A-549 is the gold-standard genetic tool — it produces functional ADAM17 disruption in NSCLC context and enables clean single-paralog rescue for paralog-specific lung cancer biology studies. This product complements the parallel double knockout in HEK293. The model is valuable for studying ADAM17 inhibitor mechanisms (e.g., aderbasib, INCB7839) and for testing tumor cell-intrinsic ADAM17/iRhom contributions to NSCLC biology distinct from immune cell-derived effects.

Primary applications: • Lung cancer ADAM17 dependency: assessment of NSCLC phenotypes (proliferation, EGFR signaling, migration) under functional ADAM17 null conditions. • ADAM17 inhibitor lung cancer studies: critical genetic control for aderbasib, INCB7839, and antibody-based ADAM17 inhibitors in NSCLC drug development. • Tumor cell-intrinsic effects: distinguishing tumor cell ADAM17/iRhom contributions from immune cell-derived effects in the lung cancer context. • Paralog-specific rescue: single iRhom1 or iRhom2 rescue in the lung cancer background for tissue-relevant paralog dissection. EDITGENE recommends this A-549-based double knockout for lung cancer ADAM17/iRhom research; the parallel HEK293 double knockout complements for biochemistry.

Yes, and rescue experiments are uniquely valuable in this lung-cancer double knockout: • Single-iRhom rescue: re-introduction of iRhom1 alone or iRhom2 alone enables paralog-specific functional dissection in lung cancer context — the gold-standard design. • Lung cancer-specific readouts: rescue should restore EGFR ligand shedding, autocrine EGFR signaling, and lung cancer-relevant proliferation/migration phenotypes. • Construct design: codon-modified RHBDF1 or RHBDF2 sequences with small C-terminal tags (FLAG, HA). • Therapeutic context: paralog-specific rescue informs which iRhom should be targeted for lung cancer ADAM17 modulation strategies. A-549 transduces efficiently with lentivirus and supports systematic paralog-specific rescue experiments in a lung cancer-relevant background.